Mesalazine-induced aplastic anemia

Am J Gastroenterol. 2009 Apr;104(4):1063. doi: 10.1038/ajg.2008.164. Epub 2009 Mar 3.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anemia, Aplastic / chemically induced*
  • Anemia, Aplastic / diagnosis
  • Anemia, Aplastic / drug therapy
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antilymphocyte Serum / therapeutic use
  • Crohn Disease / drug therapy
  • Diagnosis, Differential
  • Drug Therapy, Combination
  • Female
  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Mesalamine / adverse effects*
  • Mesalamine / therapeutic use
  • Middle Aged
  • Recombinant Proteins
  • Risk Factors

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antilymphocyte Serum
  • Immunosuppressive Agents
  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Mesalamine
  • Filgrastim